Top listeners:

skip_previous skip_next
00:00 00:00
playlist_play chevron_left
  • cover play_arrow

    94.3 Rev-FM The Rock of Texas | Where Texas Rocks

  • cover play_arrow

    99.1 The Buck Texas Country's Number 1 Country

  • cover play_arrow

    103.7 MikeFM Your Texas Hill Country Mix Tape

  • cover play_arrow

    KERV 1230 AM

  • cover play_arrow

    JAM Sports 1 JAM Broadcasting Sports 1

  • cover play_arrow

    JAM Sports 2 JAM Broadcasting Sports 2

Local News

Peterson Health hosting Johnson and Johnson vaccine clinic Thursday

todayMay 10, 2021

share close

As Kerr County saw its number of active COVID-19 cases in the county increase slightly from the week before, a mass vaccine clinic will be offered this Thursday, May 13, in an effort to curb the future spread of the novel coronavirus.

Peterson Health will administer the one-dose Johnson & Johnson vaccine, according to Kerr County Emergency Management Coordinator Dub Thomas. Anyone wanting the shot can schedule an appointment on the Peterson Health website at www. and click on the link that says “COVID-19 Vaccine Self Scheduler.”

For those without a computer with internet access, appointments can be scheduled by calling (830) 258-7373, and choosing Option 2 weekdays from 8 a.m.-5 p.m.

As of May 10, the Texas Department of State Health Services Region 8 and Peterson Health are reporting the following: 50 active cases; 4,335 recoveries; 88 deaths; 5 hospitalizations.

The DSHS is reporting that 30,151 total vaccines have been administered to Kerr County residents. This number reflects the number of doses administered, the number of people vaccinated with one dose and the number of people fully vaccinated, aggregated by county of residence.

According to state data, 13,558 Kerr County residents are fully vaccinated and 17,731 county residents have had at least one dose.

The US Food and Drug Administration expanded the emergency use authorization for Pfizer’s COVID-19 vaccine on Monday to include people ages 12 to 15. This is the first COVID-19 vaccine in the United States authorized for use in younger teens and adolescents.

The FDA reviewed data submitted by Pfizer. The company said at the end of March that a clinical trial involving 2,260 12-to-15 year-olds showed the vaccine’s efficacy is 100% and is well tolerated.


Written by: Michelle Layton

Rate it